Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer

Endometrial cancer (EC) stands as one of the most prevalent gynecological malignancies affecting women, with its incidence and disease-related mortality steadily on the rise. Disulfiram (DSF), an FDA-approved medication primarily used for treating alcohol addiction, has exhibited promising anti-tumo...

Full description

Bibliographic Details
Main Authors: Lijun Yang, Cancan Yao, Zhenning Su, Yihao Fang, Nil Kanatha Pandey, Eric Amador, Tian Diao, Guo Bao, Derong Cao, Xihua Chen, Xiangbo Xu, Bin He, Yufeng Zheng, Wei Chen
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-06-01
Series:Bioactive Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X24000549
_version_ 1797287581610672128
author Lijun Yang
Cancan Yao
Zhenning Su
Yihao Fang
Nil Kanatha Pandey
Eric Amador
Tian Diao
Guo Bao
Derong Cao
Xihua Chen
Xiangbo Xu
Bin He
Yufeng Zheng
Wei Chen
author_facet Lijun Yang
Cancan Yao
Zhenning Su
Yihao Fang
Nil Kanatha Pandey
Eric Amador
Tian Diao
Guo Bao
Derong Cao
Xihua Chen
Xiangbo Xu
Bin He
Yufeng Zheng
Wei Chen
author_sort Lijun Yang
collection DOAJ
description Endometrial cancer (EC) stands as one of the most prevalent gynecological malignancies affecting women, with its incidence and disease-related mortality steadily on the rise. Disulfiram (DSF), an FDA-approved medication primarily used for treating alcohol addiction, has exhibited promising anti-tumor properties. Studies have revealed DSF's capacity for enhanced anti-tumor activity, particularly when combined with copper. The novel Copper-Cysteamine (CuCy) compound, Cu3Cl(SR)2 (RCH2CH2NH2), showcases photodynamic effects and demonstrates significant anti-tumor potential under various conditions, including exposure to ultraviolet light, X-ray, microwave, and ultrasound. This study delves into exploring the synergistic anti-tumor effects and underlying mechanisms by utilizing copper-cysteamine in conjunction with DSF against endometrial cancer. The investigation involved comprehensive analyses encompassing in vitro experiments utilizing Ishikawa cells, in vivo studies, and transcriptomic analyses. Remarkably, the combined administration of both compounds at a low dose of 0.5 μM exhibited pronounced efficacy in impeding tumor growth, inhibiting blood vessel formation, and stimulating cell apoptosis. Notably, experiments involving transplanted tumors in nude mice vividly demonstrated the significant in vivo anti-tumor effects of this combination treatment. Detailed examination through transmission electron microscopy unveiled compelling evidence of mitochondrial damage, cellular swelling, and rupture, indicative of apoptotic changes in morphology due to the combined treatment. Moreover, transcriptomic analysis unveiled substantial downregulation of mitochondrial-related genes at the molecular level, coupled with a significant hindrance in the DNA repair pathway. These findings strongly suggest that the combined application of CuCy and DSF induces mitochondrial impairment in Ishikawa cells, thereby fostering apoptosis and ultimately yielding potent anti-tumor effects.
first_indexed 2024-03-07T18:36:20Z
format Article
id doaj.art-8a552fbc970c430f9cd059af54f88c63
institution Directory Open Access Journal
issn 2452-199X
language English
last_indexed 2024-03-07T18:36:20Z
publishDate 2024-06-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Bioactive Materials
spelling doaj.art-8a552fbc970c430f9cd059af54f88c632024-03-02T04:54:35ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2024-06-013696111Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancerLijun Yang0Cancan Yao1Zhenning Su2Yihao Fang3Nil Kanatha Pandey4Eric Amador5Tian Diao6Guo Bao7Derong Cao8Xihua Chen9Xiangbo Xu10Bin He11Yufeng Zheng12Wei Chen13Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China; NHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaChinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China; NHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaChinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China; NHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaState Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, 510641, ChinaSchool of CHIPS, Xian-Jiaotong Liverpool University, Suzhou 215123, China; Department of Physics, University of Texas at Arlington, Arlington, TX, 76013, USASchool of CHIPS, Xian-Jiaotong Liverpool University, Suzhou 215123, China; Department of Physics, University of Texas at Arlington, Arlington, TX, 76013, USAChinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China; NHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaNHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaState Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, 510641, ChinaNHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaNHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, ChinaNHC Key Laboratory of Reproductive Health Engineering Technology Research, Department of Reproduction and Physiology, National Research Institute for Family Planning, Beijing 100081, China; Corresponding author.Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China; School of Materials Science and Engineering, Peking University, Beijing, 100871, China; Corresponding author. Graduate School of Peking Union Medical College, Beijing, 100730, China.School of CHIPS, Xian-Jiaotong Liverpool University, Suzhou 215123, China; Department of Physics, University of Texas at Arlington, Arlington, TX, 76013, USA; Corresponding author. Department of Physics, University of Texas at Arlington, Arlington, TX, 76013, USA.Endometrial cancer (EC) stands as one of the most prevalent gynecological malignancies affecting women, with its incidence and disease-related mortality steadily on the rise. Disulfiram (DSF), an FDA-approved medication primarily used for treating alcohol addiction, has exhibited promising anti-tumor properties. Studies have revealed DSF's capacity for enhanced anti-tumor activity, particularly when combined with copper. The novel Copper-Cysteamine (CuCy) compound, Cu3Cl(SR)2 (RCH2CH2NH2), showcases photodynamic effects and demonstrates significant anti-tumor potential under various conditions, including exposure to ultraviolet light, X-ray, microwave, and ultrasound. This study delves into exploring the synergistic anti-tumor effects and underlying mechanisms by utilizing copper-cysteamine in conjunction with DSF against endometrial cancer. The investigation involved comprehensive analyses encompassing in vitro experiments utilizing Ishikawa cells, in vivo studies, and transcriptomic analyses. Remarkably, the combined administration of both compounds at a low dose of 0.5 μM exhibited pronounced efficacy in impeding tumor growth, inhibiting blood vessel formation, and stimulating cell apoptosis. Notably, experiments involving transplanted tumors in nude mice vividly demonstrated the significant in vivo anti-tumor effects of this combination treatment. Detailed examination through transmission electron microscopy unveiled compelling evidence of mitochondrial damage, cellular swelling, and rupture, indicative of apoptotic changes in morphology due to the combined treatment. Moreover, transcriptomic analysis unveiled substantial downregulation of mitochondrial-related genes at the molecular level, coupled with a significant hindrance in the DNA repair pathway. These findings strongly suggest that the combined application of CuCy and DSF induces mitochondrial impairment in Ishikawa cells, thereby fostering apoptosis and ultimately yielding potent anti-tumor effects.http://www.sciencedirect.com/science/article/pii/S2452199X24000549CombinationDisulfiramCopper−Cysteamine nanoparticlesMitochondria damagePromotes apoptosis in Endometrial Cancer
spellingShingle Lijun Yang
Cancan Yao
Zhenning Su
Yihao Fang
Nil Kanatha Pandey
Eric Amador
Tian Diao
Guo Bao
Derong Cao
Xihua Chen
Xiangbo Xu
Bin He
Yufeng Zheng
Wei Chen
Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
Bioactive Materials
Combination
Disulfiram
Copper−Cysteamine nanoparticles
Mitochondria damage
Promotes apoptosis in Endometrial Cancer
title Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
title_full Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
title_fullStr Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
title_full_unstemmed Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
title_short Combination of disulfiram and Copper−Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
title_sort combination of disulfiram and copper cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
topic Combination
Disulfiram
Copper−Cysteamine nanoparticles
Mitochondria damage
Promotes apoptosis in Endometrial Cancer
url http://www.sciencedirect.com/science/article/pii/S2452199X24000549
work_keys_str_mv AT lijunyang combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT cancanyao combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT zhenningsu combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT yihaofang combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT nilkanathapandey combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT ericamador combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT tiandiao combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT guobao combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT derongcao combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT xihuachen combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT xiangboxu combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT binhe combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT yufengzheng combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer
AT weichen combinationofdisulfiramandcoppercysteaminenanoparticlesinducesmitochondriadamageandpromotesapoptosisinendometrialcancer